Gefitinib vs Trastuzumab

Gefitinib vs Trastuzumab: Overview

This comparison examines the pharmacological differences between Gefitinib and Trastuzumab.

Mechanism of Action

Gefitinib: Selective reversible inhibitor of EGFR tyrosine kinase.

Trastuzumab: Anti-HER2 monoclonal antibody inhibiting receptor signaling.

Pharmacokinetics

Half-life: Gefitinib — 48 hours; Trastuzumab — 28 days.

Chemical Properties

Molecular Formula: Gefitinib — C22H24ClFN4O3.

Molecular Weight: Gefitinib — 446.9000 g/mol.

Type: Gefitinib — Small molecule; Trastuzumab — Antibody.